Evidence map›Paper›PMID 35328471›Full record

ReviewInternational journal of molecular sciences2022

Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?

Maria de Los Angeles Robinson-Agramonte, Elena Noris García, Jarasca Fraga Guerra, Yamilé Vega Hurtado, Nicola Antonucci, Neomar Semprún-Hernández, Stephen Schultz, Dario Siniscalco

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 2 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 2 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Maria de Los Angeles Robinson-AgramonteNeuroimmunology Department, International Center for Neurological Restoration, Havana 11300, Cuba.
Elena Noris GarcíaImmunology Department, National Institute of Nephrology, Havana 10600, Cuba.
Jarasca Fraga GuerraMicrobiology Department, National Institute of Nephrology, Havana 10600, Cuba.
Yamilé Vega HurtadoResearch Center, International Center for Neurological Restoration, Havana 11300, Cuba.
Nicola AntonucciBiomedical Centre for Autism Research and Treatment, 70126 Bari, Italy.
Neomar Semprún-HernándezResearch Division, Autism Immunology Unit of Maracaibo, Catedra Libre de Autismo, Universidad del Zulia, Maracaibo 4001, Venezuela.ORCID 0000-0002-6635-4376
Stephen SchultzDepartment of Cellular and Integrative Physiology, Center for Biomedical Neuroscience, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Dario SiniscalcoDepartment of Experimental Medicine, University of Campania, 80138 Naples, Italy.ORCID 0000-0002-3779-2596
International Center of Neurologic Restoration · CUEuropean Biomedical Research Institute of Salerno · ITThe University of Texas Health Science Center at San Antonio · USUniversidad del Zulia · VE

Funding

Cuban National Program of Neuroscience and Neurothecnology PN305LH013-056
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a group of complex multifactorial neurodevelopmental disorders characterized by a wide and variable set of neuropsychiatric symptoms, including deficits in social communication, narrow and restricted interests, and repetitive behavior. The immune hypothesis is considered to be a major factor contributing to autism pathogenesis, as well as a way to explain the differences of the clinical phenotypes and comorbidities influencing disease course and severity. Evidence highlights a link between immune dysfunction and behavioral traits in autism from several types of evidence found in both cerebrospinal fluid and peripheral blood and their utility to identify autistic subgroups with specific immunophenotypes; underlying behavioral symptoms are also shown. This review summarizes current insights into immune dysfunction in ASD, with particular reference to the impact of immunological factors related to the maternal influence of autism development; comorbidities influencing autism disease course and severity; and others factors with particular relevance, including obesity. Finally, we described main elements of similarities between immunopathology overlapping neurodevelopmental and neurodegenerative disorders, taking as examples autism and Parkinson Disease, respectively.

Indexed as

Autism Spectrum DisorderAutistic DisorderImmune System DiseasesNeurodevelopmental DisordersHumansadaptive immunityautism spectrum disorder (ASD)autoimmunitycytokineshuman leukocyte antigens (HLA) allelesinnate immunitymajor histocompatibility complex (MHC)neurodegenerative diseasesneuroimmunologyneuropsychiatric disordersobesityT helper (Th) cells

Identifiers

PMID35328471
PMCPMC8955336
OpenAlexW4221044978

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.